Live feed
Filing
SC 13G/A
SC 13G/A0001193125-18-045175·CytomX Therapeutics, Inc.
Schedule 13G ownership disclosure
CytomX Therapeutics Inc
Security class unavailable · CUSIP: 23284F105
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-045175
- Form type
- SC 13G/A
- Filer
- CytomX Therapeutics, Inc.
- CIK
- CIK 1501989
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership